✦ LIBER ✦

Lymphocyte subpopulations in Hodgkin's disease and non-Hodgkin's lymphoma and the effects of radiotherapy

✍ Scribed by A.N. Balasem; C.R. Barker

Book ID: 117080078
Publisher: Elsevier Science
Year: 1984
Tongue: English
Weight: 584 KB
Volume: 35
Category: Article
ISSN: 0009-9260
DOI: 10.1016/s0009-9260(84)80175-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

T-lymphocyte subpopulations in B-cell-de

T-lymphocyte subpopulations in B-cell-derived non-hodgkin's lymphomas and hodgkin's disease

✍ Daniel M. Knowles II; James P. Halper; Frederick A. Jakobiec 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 914 KB

Role of radiotherapy in non-Hodgkin's ly

Role of radiotherapy in non-Hodgkin's lymphoma and Hodgkin's disease in childhood

✍ Barrett, A. 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 171 KB

T-cell non-hodgkin's lymphoma after radi

T-cell non-hodgkin's lymphoma after radiotherapy and chemotherapy for hodgkin's disease

✍ Raymond M. Lowenthal; Roger W. H. Harlow; Anne E. Mead; Deirdre Tuck; David R. C 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 539 KB

Epidemiology of Hodgkin's disease and no

Epidemiology of Hodgkin's disease and non-Hodgkin's lymphoma

✍ A. J. Swerdlow 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 178 KB

Management of childhood lymphomas—Hodgki

Management of childhood lymphomas—Hodgkin's disease and non-Hodgkin's lymphomas

✍ Chandrakant C. Patel 📂 Article 📅 1981 🏛 Springer-Verlag 🌐 English ⚖ 522 KB

Evaluation of the circulating and spleni

Evaluation of the circulating and splenic lymphocyte subpopulations in patients with non-hodgkin lymphomas and Hodgkin's disease using monoclonal antibodies

✍ Herrmann, F. ;Sieber, G. ;Jauer, B. ;Lochner, A. ;Komischke, B. ;R�hl, H. 📂 Article 📅 1983 🏛 Springer-Verlag ⚖ 587 KB

The number of B lymphocytes, T lymphocytes and their helper/inducer, cytotoxic/suppressor and NK/K subpopulations was measured in peripheral blood and spleen cell suspensions from patients with Hodgkin's disease (HD) in the active stage of the disease and in remission status, as well as in Non-Hodgk